High Risk For Cardiovascular Event
📧 Sign up to get email alerts when something new happens for High Risk For Cardiovascular Event.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-12-26Clinical Trial Update: Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events [Phase 3]
Phase 3 multicenter trial evaluating the effect of dapagliflozin on incidence of cardiovascular events in high-risk type 2 diabetes patients…